Skip to main content


Cardinal Health pulls back from China with $557M sale to Hong Kong firm

By The Wall Street Journal  
   November 15, 2017

Cardinal Health Inc. has agreed to sell its Chinese pharmaceutical and medical-products distribution business to a local rival, in the latest pullback by a U.S. company in the world’s second-largest economy.

Full story

Get the latest on healthcare leadership in your inbox.